Immunosuppressive Function of Bone Marrow Mesenchymal Stem Cells on Acute Rejection of Liver Allografts in Rats

Transplantation Proceedings

Volumn 41, Issue 1, 2009, Pages 403-409

  Hong, Z F ^a   Huang, X J ^a   Yin, Z Y ^a   Zhao, W X ^a   Wang, X M ^a  

^a XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN PDL 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL HOMING; CONTROLLED STUDY; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; MESENCHYMAL STEM CELL; MIXED LYMPHOCYTE REACTION; NONHUMAN; PRIORITY JOURNAL; RAT; STAINING;

ANIMALS; ANTIGENS, CD45; ANTIGENS, THY-1; BONE MARROW TRANSPLANTATION; EPITOPES; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GRAFT REJECTION; IMMUNOSUPPRESSION; LIVER TRANSPLANTATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; RATS; RATS, INBRED BN; SEX-DETERMINING REGION Y PROTEIN; TRANSPLANTATION CHIMERA; Y CHROMOSOME;

EID: 60649090021     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.10.020     Document Type: Article

References (20)

1. Friedenstein A.J., Petrakova K.V., Kurolesova A.I., et al. Heterotopic of bone marrow: analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6 (1968) 230
2. Klyushnenkova E., Mosca J.D., Zernetkina V., et al. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci 12 (2005) 47
3. Kamada N., and Calne R.Y. A surgical experience with five hundred thirty liver transplants in the rat. Surgery 93 (1983) 64
4. Krampera M., Cosmi L., Angeli R., et al. Role for interferon-γ in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24 (2006) 386
5. Ryan J.M., Barry F., Murphy J.M., et al. Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol 149 (2007) 353
6. Le Blanc K., Samuelsson H., Gustafsson B., et al. Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia 21 (2007) 1733
7. Bartholomew A., Sturgeon C., Siatskas M., et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30 (2002) 42
8. Stagg J. Immunoregulation by mesenchymal stem cells: two sides to the coin. Tissue Antigens 69 (2007) 1
9. Sylwia B., Danuta J., and Marcin M. Mesenchymal stem cells: characteristics and clinical applications. Folisa Histochem Cytobiolog 44 (2006) 215
10. Carvalho K.A., Oliveira L., Malvezzi M., et al. Immunophenotypic expression by flow cytometric analysis of cocultured skeletal muscle and bone marrow mesenchymal stem cells for therapy into myocardium. Transplant Proc 40 (2008) 842
11. Guarita-Souza L.C., Carvalho K.A., Simeone B.R., et al. Functional outcome of bone marrow stem cells: mononuclear versus mesenchymal stem cells after cellular therapy in myocardial scar in Wistar rats. Transplant Proc 38 (2006) 1953
12. Reyes M., Dudek A., Jahagirdar B., et al. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109 (2002) 337
13. Kao C.L., Lin H.T., Chen Y.W., et al. Fibronectin suppresses lipopolysaccharide-induced liver damage and promotes the cytoprotection abilities of hepatocyte-like cells derived from human bone marrow mesenchymal stem cells. Transplant Proc 39 (2007) 3444
14. Liechty K.W., MacKenzie T.C., Shaaban A.F., et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6 (2000) 1282
15. Rasmusson I., Ringden O., Sundberg B., et al. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 76 (2003) 1208
16. Angoulvant D., Clerc A., Benchalal S., et al. Human mesenchymal stem cells suppress induction of cytotoxic response to alloantigens. Biorheology 41 (2004) 469
17. Itakura S., Asari S., Rawson J., et al. Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat. Am J Transplant 7 (2007) 336
18. Augello A., Tasso R., Negrini S.M., et al. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death-1 pathway. Eur J Immunol 35 (2005) 1482
19. Tse W.T., Pendleton J.D., Beyer W.M., et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75 (2003) 389
20. Ren G., Zhang L., Zhao X., et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2 (2008) 141